Cardio-Oncology (DoD)

Title: Characterization of TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and heart failure in women

Summary: To identify genetic variants that increase patient risk of chemotherapy-related cardiotoxicity and pre-clinical studies of novel cardioprotective agents.

Role: Co-Investigator and University of Florida Site Principal Investigator

Funding Source: Department of Defense (DOD)

Timeline: 7/1/2022-6/30/2026